Market Trends Axsome stock slips as depression trial fails (AXSM:NASDAQ)By admin8996erT0allApril 1, 2025 BlackSalmonAxsome Therapeutics (NASDAQ:AXSM) traded lower in the premarket on Tuesday after the company said solriamfetol, its experimental therapy for depression,…
Market Trends Axsome reports mixed results for Alzheimer’s agitation drugBy admin8996erT0allDecember 30, 2024 IvelinRadkovAxsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or…
